Six months ago, the researchers
and activists involved in this
report set out to understand why
the world is missing the target
on a goal it set back in 2001: to
reduce the rate of HIV infections
from mothers to babies by half.
What emerged was evidence that
the global institutions in charge
have been cooking the statistical
books. Despite the success they’ve
proclaimed, they’re nowhere near
the target. They haven’t even been
aiming for it.
On paper, the global program
called ‘Prevention of Mother-to-
Child Transmission’ is a model of
sound design and human rights
principles. Its four prongs cover
the gamut from prevention to
counselling to treatment.
In practice, the program is a
shameful example of double
standards.
We remember well the elation in
the mid-90s at our former office
in UNICEF headquarters, when
results emerged from clinical trials
in Uganda and Thailand. The risk
of vertical transmission – passage
of the virus from one generation
to the next – could be slashed,
thanks to simple, relatively low-
cost drug regimens for mothers
and infants. An 11-country pilot
project was spearheaded by UNICEF
and assisted by the World Health
Organization, and the good news/
bad news rollercoaster ride began.
The first low point came with the
pilot projects’ title: Prevention of
Mother-to-Child Transmission, or
PMTCT – a name that implies that
mothers are the source of the virus,
rather than the latest link in a long
chain of transmission.
In 2000 came good news: the
pharmaceutical company
Boehringer Ingelheim announced
that for the next five years, any
developing country could request
free supplies of its antiretroviral
drug nevirapine – a single dose
of which, administered during
labour to an HIV-positive woman
and immediately after birth to her
baby, was then believed to cut by
half the risk of transmission (now
we know that it’s actually two-
fifths). Buoyed by the possibilities,
the world’s governments made a
commitment in 2001 to reduce
infant infections by 20 percent by
2005, and 50 percent by 2010.
Suddenly, silence. For years, in
report after report issued by
UNAIDS, the global Prevention
of Mother-to-Child Transmission
program barely got an honourable
mention. By 2003, 95 percent of the
HIV-positive pregnant women in
sub-Saharan Africa, the pandemic’s
epicenter, were not receiving any
services at all to prevent vertical
transmission. UNICEF went back
and forth on infant feeding. Like
so many other programs targeting
women, everyone and no one at
the UN seemed to be in charge.
Wealthy nations were bringing
their transmission rates down to
negligible levels. Overall, for poor
women in developing countries,
coverage stalled at 9 percent as
rates of paediatric infection soared.
Scale-up was slow, uptake was low,
and no one seemed to know why.
Experts offered reasons: women
refuse testing; women don’t return
for test results; women given drugs
to self-administer don’t take them
properly. The problems, it seemed,
were caused by the women.
In the meantime, researchers were
concluding that for most of the
world’s babies born to mothers
with HIV, the best guarantee of
HIV-free survival at a year and
a half was a diet of nothing but
breastmilk for the first six months.
But most women didn’t breast-
feed exclusively. The UN’s ardour
for explaining breast-feeding to
women had diminished as the
issue became more complex: babies
needed to be fed all breastmilk,
or all breastmilk replacements
such as formula; mixing the two
could kill them. Before a mother
chose not to breast-feed, she’d first
need to assess whether for her,
replacements met five criteria:
acceptable, feasible, affordable,
safe and sustainable (AFASS).
And then the most difficult risk
to weigh: without the nutrients
and immunities in mother’s
milk, the baby could die of other
causes. Before long, in developing
countries that provided formula
and encouraged women with HIV
to avoid breast-feeding, many
babies did die.
About two years ago, we began to
notice a triumphant tone in reports
of vertical transmission from global
agencies. All heralded the fact that
coverage was finally climbing.
In 2008, cautiously optimistic,
AIDS-Free World accepted an
invitation to join TMAP in its
own assessment.